Jim Cramer: Sell Acadia, Achillion, and Ariad, But Buy This Stock
Jim Cramer made the following calls on October 10th, 2013. What do you think about his picks?
ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Buy on October 1, 2013. The stock’s 52-week high is $29.73, and its 52-week low is $1.80. Cramer said that it was time to get out of Acadia Pharmaceuticals. Though he liked the company, he said that gains of nearly 300 percent should satisfy most investors, and that at a certain point profits have to be harvested from a stock.